Gevo and Praj Sign Bio-IBA Commercialization Deal for India
GEVO sits 15% above its 52-week low of $1.37.
Summary
Gevo and Praj Industries signed a Development & Commercialization Agreement granting Praj exclusive rights to deploy Gevo's Bio-IBA technology in India, targeting diesel blending in one of the world's largest diesel markets. Praj is also building India's first commercial Bio-IBA demonstration plant for a leading oil marketing company using Gevo's licensed technology. This expands Gevo's addressable market beyond its core U.S. SAF and RNG operations, leveraging Praj's engineering and feedstock expertise. The agreement follows Gevo's recent pivot away from the ATJ-60 project and its raised 2026 EBITDA guidance driven by carbon credit sales. While no immediate revenue is disclosed, the partnership validates Gevo's technology and opens a large potential market for licensing and royalties.
At the time of this announcement, GEVO was trading at $1.58 on NASDAQ in the Energy & Transportation sector, with a market capitalization of approximately $388.2M. The 52-week trading range was $1.37 to $2.97. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.